Lakewood Capital Management LP Has $97.23 Million Holdings in Cigna Group $CI

Lakewood Capital Management LP cut its stake in Cigna Group (NYSE:CI) by 8.1% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 337,307 shares of the health services provider’s stock after selling 29,800 shares during the quarter. Cigna Group makes up approximately 7.3% of Lakewood Capital Management LP’s investment portfolio, making the stock its 2nd largest holding. Lakewood Capital Management LP owned approximately 0.13% of Cigna Group worth $97,229,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also modified their holdings of the company. Brighton Jones LLC boosted its holdings in shares of Cigna Group by 9.3% during the fourth quarter. Brighton Jones LLC now owns 3,736 shares of the health services provider’s stock worth $1,032,000 after acquiring an additional 318 shares during the period. Sivia Capital Partners LLC grew its position in shares of Cigna Group by 10.4% in the second quarter. Sivia Capital Partners LLC now owns 1,160 shares of the health services provider’s stock valued at $384,000 after purchasing an additional 109 shares during the last quarter. SBI Securities Co. Ltd. increased its stake in shares of Cigna Group by 15.1% during the second quarter. SBI Securities Co. Ltd. now owns 458 shares of the health services provider’s stock worth $151,000 after purchasing an additional 60 shares during the period. Bailard Inc. lifted its holdings in Cigna Group by 1.4% during the 2nd quarter. Bailard Inc. now owns 5,464 shares of the health services provider’s stock worth $1,806,000 after purchasing an additional 78 shares during the last quarter. Finally, Police & Firemen s Retirement System of New Jersey boosted its stake in Cigna Group by 4.0% in the 2nd quarter. Police & Firemen s Retirement System of New Jersey now owns 40,636 shares of the health services provider’s stock valued at $13,433,000 after purchasing an additional 1,561 shares during the period. Institutional investors own 86.99% of the company’s stock.

Cigna Group News Summary

Here are the key news stories impacting Cigna Group this week:

• Positive Sentiment: Sanford C. Bernstein upgraded Cigna to “outperform” and raised its price target to $358, citing PBM reform as a clearing event and improved outlook for Evernorth — a catalyst for multiple analysts to raise estimates. Bernstein upgrades CVS and Cigna, citing PBM reform as key clearing event
• Positive Sentiment: Zacks notes CI trades below the industry P/E and highlights Evernorth growth, steady earnings beats and buybacks as supports for the investment case — a valuation/earnings combo that helps explain buying interest. Cigna Stock Trades Below Industry P/E: Is It Worth Holding Now?
• Neutral Sentiment: A valuation review highlights recent share-price weakness versus the specialty-pharmacy growth narrative — useful context for investors weighing whether current discounts already reflect execution risks. Evaluating Cigna Group (CI) Valuation After Recent Share Price Weakness And Specialty Pharmacy Growth Narrative
• Neutral Sentiment: A head-to-head comparison with CVS frames Cigna as the play for stronger earnings quality and capital discipline, while reminding long-term investors to consider income, stability and valuation differences when choosing exposure. CVS vs Cigna: Which Healthcare Giant Belongs in Your Retirement Portfolio?
• Neutral Sentiment: Zacks’ broader industry outlook continues to single out major HMOs (including Cigna) as key players in a sector balancing tech-enabled growth and policy/operational headwinds. Zacks Industry Outlook Highlights UnitedHealth, The Cigna, Humana and Centene
• Negative Sentiment: Barclays and commentators warn that the timing of a CEO change could surprise investors and introduce strategic/operational uncertainty during a critical execution window. Management transition risk may weigh on sentiment until plans are clearer. The Cigna Group (CI) CEO Change Timing May Come As Surprise to Some Investors, According to Barclays
• Negative Sentiment: Industry pieces flag escalating medical costs, nursing shortages and margin pressure as sector-wide risks that could blunt near-term earnings leverage for HMOs, including Cigna. 4 HMO Stocks to Watch Despite Escalating Costs, Nursing Shortage

Analysts Set New Price Targets

CI has been the topic of several recent research reports. Jefferies Financial Group increased their price objective on Cigna Group from $310.00 to $333.00 and gave the stock a “buy” rating in a research report on Monday, February 9th. Piper Sandler reduced their target price on shares of Cigna Group from $374.00 to $370.00 and set an “overweight” rating for the company in a research report on Tuesday, March 3rd. Mizuho set a $325.00 price target on shares of Cigna Group in a research report on Friday, January 9th. Deutsche Bank Aktiengesellschaft boosted their price objective on shares of Cigna Group from $301.00 to $304.00 and gave the company a “buy” rating in a report on Tuesday, February 10th. Finally, Barclays lowered their target price on shares of Cigna Group from $305.00 to $303.00 and set an “overweight” rating on the stock in a report on Friday, February 6th. One research analyst has rated the stock with a Strong Buy rating, seventeen have given a Buy rating and four have assigned a Hold rating to the stock. According to MarketBeat, Cigna Group presently has an average rating of “Moderate Buy” and a consensus price target of $333.11.

Cigna Group Stock Up 0.5%

CI stock opened at $267.15 on Friday. Cigna Group has a 52 week low of $239.51 and a 52 week high of $350.00. The business has a 50-day simple moving average of $279.60 and a 200 day simple moving average of $282.94. The company has a quick ratio of 0.74, a current ratio of 0.74 and a debt-to-equity ratio of 0.74. The company has a market cap of $70.40 billion, a PE ratio of 12.04, a price-to-earnings-growth ratio of 0.92 and a beta of 0.27.

Cigna Group (NYSE:CI) last announced its quarterly earnings data on Thursday, February 5th. The health services provider reported $8.08 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $7.88 by $0.20. Cigna Group had a net margin of 2.17% and a return on equity of 19.46%. The firm had revenue of $72.50 billion for the quarter, compared to the consensus estimate of $69.53 billion. During the same period in the prior year, the company posted $6.64 earnings per share. The business’s revenue for the quarter was up 10.4% on a year-over-year basis. Cigna Group has set its FY 2026 guidance at 30.250- EPS. Sell-side analysts anticipate that Cigna Group will post 29.77 EPS for the current fiscal year.

Cigna Group Increases Dividend

The company also recently declared a quarterly dividend, which will be paid on Thursday, March 19th. Investors of record on Thursday, March 5th will be given a dividend of $1.56 per share. The ex-dividend date is Thursday, March 5th. This represents a $6.24 annualized dividend and a dividend yield of 2.3%. This is a positive change from Cigna Group’s previous quarterly dividend of $1.51. Cigna Group’s dividend payout ratio (DPR) is 28.13%.

Insider Buying and Selling

In other Cigna Group news, insider Nicole S. Jones sold 2,307 shares of the company’s stock in a transaction on Monday, March 2nd. The stock was sold at an average price of $288.91, for a total transaction of $666,515.37. Following the completion of the sale, the insider directly owned 32,647 shares in the company, valued at $9,432,044.77. This represents a 6.60% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, insider Everett Neville sold 1,719 shares of the firm’s stock in a transaction on Monday, March 2nd. The shares were sold at an average price of $288.91, for a total value of $496,636.29. Following the completion of the sale, the insider directly owned 5,670 shares in the company, valued at approximately $1,638,119.70. This represents a 23.26% decrease in their position. The SEC filing for this sale provides additional information. Company insiders own 0.70% of the company’s stock.

Cigna Group Profile

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.